Skip to content

Virtual reality-guided mindfulness intervention to enhance psychosocial well-being in caregivers of end-stage kidney disease patients: protocol for a mixed-methods pilot randomised controlled trial

Amartya Mukhopadhyay, Ravi Shankar, Wei Zhen Hong, Anjali Bundele, Koh Pei Si

BMJ Open October 26, 2024 DOI: 10.1136/bmjopen-2024-090550 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pilot randomised controlled trial (single-centre, single-blind, parallel-group) Randomized Pilot study Peer reviewed
Sample size 30
Population Caregivers of patients with end-stage kidney disease (ESKD)
Intervention VR-guided mindfulness programme
Duration 6-week intervention; assessments at baseline, post-intervention (6 weeks) and follow-up (12 weeks)
Measures Zarit Burden Interview (ZBI), Depression Anxiety Stress Scale-21 (DASS-21), 36-Item Short Form Health Survey (SF-36), Five Facet Mindfulness Questionnaire (FFMQ)
Topics Meditation
Registration NCT06479200
Key findings The protocol describes a planned pilot trial to evaluate the efficacy and feasibility of a six-week home-based VR-guided mindfulness intervention for ESKD caregivers, compared with a sham VR control viewing relaxing nature videos. No results are reported; outcomes will include caregiver burden, stress, anxiety, depression, quality of life, mindfulness and feasibility measures.

Abstract

Introduction Caregivers of patients with end-stage kidney disease (ESKD) face significant challenges that contribute to caregiver burden, negatively impacting their psychosocial well-being. Virtual-reality (VR)-guided mindfulness interventions have shown promise in reducing stress, anxiety and depression in various populations.Methods and analysis This pilot study aims to evaluate the efficacy and feasibility of a VR-guided mindfulness intervention for ESKD caregivers. A single-centre, single-blind, parallel-group pilot randomised controlled trial will be conducted. Thirty ESKD caregivers will be randomly allocated to either the VR-guided mindfulness intervention group or the sham VR control group. The intervention group will receive a 6 week home-based VR-guided mindfulness programme, while the control group will view relaxing nature videos without mindfulness content. Participants will be assessed at baseline, post-intervention (6 weeks) and follow-up (12 weeks) using validated questionnaires for caregiver burden (Zarit Burden Interview (ZBI)), stress, anxiety, depression (Depression Anxiety Stress Scale-21 (DASS-21)), quality of life (36-Item Short Form Health Survey (SF-36)) and mindfulness (Five Facet Mindfulness Questionnaire (FFMQ)). Feasibility outcomes include accrual rates, retention, adherence, questionnaire completion and side effect rates. Semi-structured interviews will explore participants’ experiences with the intervention.Ethics and dissemination The study has been approved by the NHG Domain Specific Review Board (Reference: 2024–3940-APP1). The results of this pilot study will be reported in peer-reviewed open-access journals and shared with participants and stakeholders.Trial registration NCT06479200.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics